Using a single step chemical synthesis, we synthesized the potential tumor imaging agent Tc-diglucosediethylenetriamine (DGTA) from diethylenetriamine and natural D-glucose. 10 min Incubation of 10 mg of precursor with 50 µg of SnCl 2 ·2H 2 O at room temperature yielded over 95% of 99m Tc labeling. The stability for 6 hours in saline or human plasma was over 90%. In vitro tumor cell uptake assays using the SNU-C5 and 9 L cell lines showed that, in 0-400 mg/dL glucose medium, cell uptake of Tc-DGTA was not dependent on glucose concentration, suggesting that the two compounds have different uptake mechanisms by tumor cells.
Introduction
One of the standard imaging tools in tumor diagnosis is functional imaging by positron emission tomography (PET) with the radiolabelled glucose analog [ 99m Tc-labeled radiopharmaceuticals have a longer half-life (6 hours) and do not require high cost production facilities. 99m Tc can be easily obtained from commercial
99
Mo/ 99m Tcgenerators and can be facilely prepared by reaction with a chelating group of ligands such as N 2 S 2 , N 4 and N 3 S.
4,5
Although these chelating groups may alter the biological properties of their parent compounds, the low cost and easy preparation of 99m Tc-labeled radiopharmaceuticals provide definite advantages.
To date, several 99m Tc-labeled glucose derivatives have been prepared and tested, including 99m Tc-ethylenedicysteinedeoxyglucose (ECDG), 6,7 99m Tc(CO) 3 -deoxyglucose analogs, Radiolabeled di-, tri-and tetramer-RDG peptide analogues have shown high tumor uptake and favorable biological characteristics compared with monomer RGD peptide analogues in tumor cell and animal models.
12-14 Moreover, larger polymeric analogues had higher affinity for tumor sites than monomeric compounds from RDG analogues results, suggesting that radiolabeled di-glucose analogues may be used to target tumors. We therefore synthesized the di-glucose moiety 99m Tc-diglucosediethylenetriamine from diethylenetriamine and natural D-glucose and evaluated its in vitro characteristics as a potential tumor imaging agent for single photon emission tomography (SPECT).
Results and Discussion
Synthesis of the Ligand and Formation of the 99m Tccomplex. DGTA was synthesized as described ( Figure 1) , with a yield of 47.9%. It was chemically stable for 6 months at 0 °C.
The optimum conditions for labeling of 99m Tc-DGTA consisted of 50 µg of SnCl 2 ·2H 2 O and 10 mg of DGTA, with a labeling efficiency of 95.4 ± 2.7% at room temperature for 10 min. (n=3) To verify its chemical structure, we tried to 99m Tc-DGTA showed similar or slightly higher tumor cell uptake at 100 mg/dl than in glucose-free medium, with decreased uptake observed only at 400 mg/dl glucose. These results indicate that these two compounds are taken up by different mechanisms.
Conclusion
We synthesized 99m Tc-DGTA, a new potential tumor imaging agent, from β-D-glucose and diethylenetriamine, easily. This compound showed high labeling efficiency and stability in saline. Moreover, 99m Tc-DGTA showed higher tumor cell uptake than [ 18 F]FDG, without being highly dependent on glucose concentration. These findings indicate that, although 99m Tc-DGTA is a glucose analogue, its uptake mechanism differs from that of [ 
Experimental
Solvents and reagents were purchased from Sigma-Aldrich (Seoul, Korea).
1
H NMR spectra were obtained on a Varian Gemini 400 (Palo Alto, CA) and 13 C NMR spectra were recorded at 100 MHz. Chemical shifts are reported in parts per million (ppm, δ units) downfield from tetramethylsilane. Fast atom bombardment (FAB) mass spectra were obtained on a JMS-700 Mstation (Jeol Ltd., Tokyo, Japan). TLC and radioTLC were performed on Merck F254 silica plates and PALL ITLC SG, respectively and RadioTLC was analyzed using a Bioscan radio-TLC scanner (Washington, DC). Mo/ 99m Tc-generator (Tyco, The Netherlands).
Synthesis of Diglucosediethylenetriamine (DGTA) as a Ligand. DGTA was synthesized according to the previous paper with minor modification. 15 Briefly, diethylene triamine (1.57 mL, 14.4 mmol) was dissolved in methanol (20 mL) in an ice bath. To it was added 14.4 mL 1 M HCl/ether (14.4 mL) dropwise, the reaction mixture was stirred for 10 min and removed from the ice bath. Following the precipitation of a white solid, methanol (50 mL) was added and the reaction mixture was stirred for 20 min. To it was slowly added β-D-glucose (5.19 g, 28.8 mmol) dissolved in hot water (6 mL), and the mixture was incubated without stirring for 20 min. After stirring for 90 min, the resulting white solid precipitate was filtered and washed with methanol to removed impurities. We obtained 2.95 g of product in 47.9% yield. The synthesis scheme is shown in Figure 1 . and 1-10 mg of the ligand DGTA. After neutralization with 1 N NaOH, the mixture was incubated for 10 min at room temperature. Labeling efficiency was determined by radioTLC with ITLC, which were developed using acetone and saline, respectively. R f value of 99m Tc-DGTA is 0 in acetone and 1 with saline.
We also prepared lyophilized kits for easy preparation of 99m Tc-DGTA. Each lyophilized kit contained 50 µg of SnCl 2 ·2H 2 O and 10 mg of DGTA from radiolabeling experiments and also checked the kit stability to 6 months.
In vitro Stability of 99m Tc-DGTA. To 1 mL of human serum or saline was added 37 MBq/0.1 mL of 99m Tc-DGTA, and the mixtures were incubated at 37 o C for 6 h. The stability of 99m Tc-DGTA was analyzed at 3 and 6 h by radioTLC (n=3 each).
Tumor Cell Uptake Assay. Tumor cell uptake assay was performed to evaluate uptake of 99m Tc-DGTA and to evaluate effect of glucose concentration on tumor cell uptake. The glioma cell line 9 L (ATCC; Manassas, VA, USA) and the colon cancer cell line SNU-C5 (Korean Cell Line Bank; Seoul, Korea) were cultured in RPMI 1640 (0.05% Lglutamine, 20 mM HEPES, 50 ug/mL penicillin-streptomycin, 10% fetal bovine serum). Cells (1 × 10 6 /well) were placed in 6 well plates containing 0, 100, or 450 mg/dL Dglucose, to which were added 0.185 MBq 99m Tc-DGTA, [
18

F]FDG, and
99m TcO 4 − (3 wells each). After incubation for 1 h, the cells were washed twice with phosphate-buffered saline and trypsinized. The radiopharmaceuticals contained cells were collected, and their radioactivity was counted using a gamma counter (COBRA II, Packard, U.S.A.).
